Suppression of c-myc by Anticarcinogenic Protease Inhibitors
- 1 January 1993
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Cell cycle progression of C3H 10T½ and 3T3 cells in the absence of an increase in c-myc RNA levelsCarcinogenesis: Integrative Cancer Research, 1988
- Down regulation of c-myc, c-fos and erb-B during estrogen induced proliferation of the chick oviductBiochemical and Biophysical Research Communications, 1988
- In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenesCell, 1986
- C-Myc expression is reduced in antipain-treated proliferating C3H 10T12 cellsBiochemical and Biophysical Research Communications, 1985
- The conditions for the modification of radiation transformation in vitro by a tumor promoter and protease inhibitorsCarcinogenesis: Integrative Cancer Research, 1985
- Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumorsCell, 1985
- Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cellsNature, 1985
- Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogeneNature, 1984
- Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertionCell, 1984
- Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomasNature, 1983